DURHAM, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CHORDOMA FOUNDATION, founded in 2007, is a community nonprofit in the Medical Research sector that reported $5.4M in total revenue in fiscal year 2024. Revenue fell 28% from the prior year — a significant decline worth monitoring. Expenses of $6.8M exceeded revenue, resulting in a 27% operating deficit.
THE MISSION OF THE CHORDOMA FOUNDATION IS TO IMPROVE THE LIVES OF THOSE AFFECTED BY CHORDOMA AND LEAD THE SEARCH FOR A CURE.
(RESEARCH) TO ACCELERATE THE DEVELOPMENT OF BETTER TREATMENTS FOR CHORDOMA, WE CONDUCTED, SUPPORTED AND ENABLED HIGH-IMPACT RESEARCH SPANNING BASIC, TRANSLATIONAL AND CLINICAL SCIENCE. THIS INCLUDED...
(RESEARCH) TO ACCELERATE THE DEVELOPMENT OF BETTER TREATMENTS FOR CHORDOMA, WE CONDUCTED, SUPPORTED AND ENABLED HIGH-IMPACT RESEARCH SPANNING BASIC, TRANSLATIONAL AND CLINICAL SCIENCE. THIS INCLUDED CARRYING OUT PRECLINICAL STUDIES IN OUR LABORATORY, AWARDING RESEARCH GRANTS TO ACADEMIC INVESTIGATORS, OPERATING REPOSITORIES TO SUPPLY THE RESEARCH COMMUNITY WITH KEY RESEARCH-ENABLING RESOURCES, CONVENING SCIENTIFIC MEETINGS, AND FACILITATING THE DESIGN AND INITIATION OF WELL-JUSTIFIED CLINICAL TRIALS.
(PATIENT SERVICES) TO IMPROVE THE LIVES OF INDIVIDUALS AFFECTED BY CHORDOMA, WE HELPED PATIENTS AND THEIR FAMILIES FIND ACCURATE INFORMATION ABOUT CHORDOMA AND TREATMENT OPTIONS, OVERCOME BARRIERS TO...
(PATIENT SERVICES) TO IMPROVE THE LIVES OF INDIVIDUALS AFFECTED BY CHORDOMA, WE HELPED PATIENTS AND THEIR FAMILIES FIND ACCURATE INFORMATION ABOUT CHORDOMA AND TREATMENT OPTIONS, OVERCOME BARRIERS TO CARE, AND GET EMOTIONAL SUPPORT FROM PEERS. THIS INCLUDED DEVELOPING AND DISTRIBUTING EDUCATIONAL CONTENT, PROVIDING PATIENT NAVIGATION SERVICES, HOSTING EDUCATIONAL CONFERENCES, OPERATING AN ONLINE COMMUNITY FORUM FOR PATIENTS AND FAMILIES AND PROVIDING FINANCIAL ASSISTANCE TO INDIVIDUALS TRAVELING TO PARTICIPATE IN CLINICAL TRIALS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $5,362,824 | $7,442,618 | -0.3% |
| Expenses | $6,834,629 | $4,597,074 | +0.5% |
| Net Income | $-1,471,805 | $2,845,544 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KENNY BRIGHTON | HEAD OF PHIL | 40.00 |
Key Emp
|
$216,428 | $13,189 | $229,617 |
| DANIEL FREED | CHIEF SCIENT | 40.00 |
Key Emp
|
$204,345 | $23,214 | $227,559 |
| JOSH SOMMER | EXEC. DIR. & | 50.00 |
Officer
Director
|
$174,183 | $28,553 | $202,736 |
| SARA NICK | HEAD OF ENGA | 40.00 |
Highest
|
$142,821 | $9,699 | $152,520 |
| SHANNON LOZINSKY | DIRECTOR OF | 40.00 |
Highest
|
$121,708 | $17,888 | $139,596 |
| LEE DOLAT | SCIENTIST | 40.00 |
Highest
|
$112,452 | $15,642 | $128,094 |
| SAI PERVEEN CHEMUDUPATI | DIRECTOR OF | 40.00 |
Highest
|
$105,347 | $11,259 | $116,606 |
| JESSE BONGARTZ | HEAD OF FINA | 40.00 |
Highest
|
$100,921 | $11,209 | $112,130 |
| LESLIE ADLER | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| PAUL FELDMAN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| STEVEN GOLICK | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER HEERY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ALICIA JEFFREYS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SUSAN MAHONY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| STEVEN MANDEL | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| LAUREN MULHOLLAND | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SHREYASKUMAR PATEL | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DAVID SANDAK | CHAIR | 2.00 |
Director
|
$0 | $0 | $0 |
| MEGAN STEWART | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN THERIEN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $5,362,824 | $6,834,629 | $11,385,145 | $-1,471,805 |
| 2023 | $7,442,618 | $4,597,074 | $11,037,912 | $2,845,544 |
| 2022 | $4,886,250 | $3,088,769 | $7,599,511 | $1,797,481 |
| 2021 | $3,085,754 | $3,372,184 | $6,529,695 | $-286,430 |
| 2020 | $2,495,845 | $2,520,685 | $6,345,825 | $-24,840 |
| 2019 | $5,155,658 | $3,937,221 | $7,176,227 | $1,218,437 |
| 2018 | $2,421,189 | $2,338,881 | $4,518,951 | $82,308 |
Compare CHORDOMA FOUNDATION with other nonprofits in North Carolina and across the country.